Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: MRR

Global Neuromorphic Computing Market Report (2022 to 2027) - by Components, Deployment, Application, Industry and Geography


DUBLIN, May 24, 2022 /PRNewswire/ -- The "Global Neuromorphic Computing Market (2022-2027) by Components, Deployment, Application, Industry, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The Global Neuromorphic Computing Market is estimated to be USD 34.23 Bn in 2022 and is projected to reach USD 225.52 Bn by 2027, growing at a CAGR of 45.8%.

Market dynamics are forces that impact the prices and behaviors of the Global Neuromorphic Computing Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Applied Brain Research Inc, Aspinity Inc, Brainchip Holdings Ltd Ceryx Medical, etc.

Countries Studied

America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Neuromorphic Computing Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Neuromorphic Computing Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, The analyst has devised suitable strategies for market growth.

Why buy this report?

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics
4.1 Drivers
4.1.1 Need for Better-Performing ICS
4.1.2 Increase in Demand for Artificial Intelligence and Machine Learning
4.2 Restraints
4.2.1 Lack of R&D and Investments is Slowing Down Development of Real-World Applications
4.2.2 Complex Algorithms Increase Complexity of Designing Hardware of Neuromorphic Chips
4.2.3 Lack of Knowledge about Neuromorphic Computing
4.3 Opportunities
4.3.1 Emerging Applications Pertaining to Automation
4.3.2 Adoption of Neuromorphic Computing for Security Purposes
4.3.3 Growing Potential of AI and Neuromorphic Computing in Medical Science and Medical Imaging
4.4 Challenges
4.4.1 Applications Dependent on Software Compatibility of Neural Hardware
4.4.2 Matching a Human's Flexibility and Ability to Learn from Unstructured Stimuli Data

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis

6 Global Neuromorphic Computing Market, By Components
6.1 Introduction
6.2 Hardware
6.3 Software

7 Global Neuromorphic Computing Market, By Deployment
7.1 Introduction
7.2 Edge Computing
7.3 Cloud Computing

8 Global Neuromorphic Computing Market, By Application
8.1 Introduction
8.2 Image Recognition
8.3 Signal Recognition
8.4 Data Mining

9 Global Neuromorphic Computing Market, By Industry
9.1 Introduction
9.2 Aerospace and Defense
9.3 IT and Telecom
9.4 Automotive
9.5 Medical
9.6 Industrial
9.7 Others

10 Americas' Global Neuromorphic Computing Market
10.1 Introduction
10.2 Argentina
10.3 Brazil
10.4 Canada
10.5 Chile
10.6 Colombia
10.7 Mexico
10.8 Peru
10.9 United States
10.10 Rest of Americas

11 Europe's Global Neuromorphic Computing Market
11.1 Introduction
11.2 Austria
11.3 Belgium
11.4 Denmark
11.5 Finland
11.6 France
11.7 Germany
11.8 Italy
11.9 Netherlands
11.10 Norway
11.11 Poland
11.12 Russia
11.13 Spain
11.14 Sweden
11.15 Switzerland
11.16 United Kingdom
11.17 Rest of Europe

12 Middle East and Africa's Global Neuromorphic Computing Market
12.1 Introduction
12.2 Egypt
12.3 Israel
12.4 Qatar
12.5 Saudi Arabia
12.6 South Africa
12.7 United Arab Emirates
12.8 Rest of MEA

13 APAC's Global Neuromorphic Computing Market
13.1 Introduction
13.2 Australia
13.3 Bangladesh
13.4 China
13.5 India
13.6 Indonesia
13.7 Japan
13.8 Malaysia
13.9 Philippines
13.10 Singapore
13.11 South Korea
13.12 Sri Lanka
13.13 Thailand
13.14 Taiwan
13.15 Rest of Asia-Pacific

14 Competitive Landscape
14.1 Competitive Quadrant
14.2 Market Share Analysis
14.3 Strategic Initiatives
14.3.1 M&A and Investments
14.3.2 Partnerships and Collaborations
14.3.3 Product Developments and Improvements

15 Company Profiles
15.1 Applied Brain Research Inc
15.2 Aspinity Inc
15.3 Brainchip Holdings Ltd Ceryx Medical
15.4 Cognixion
15.5 General Vision Inc
15.6 Hewlett Packard Enterprise HRL Laboratories LLC IBM Corp Innatera Nanosystem Intel Corp Koniku
15.7 Mindmaze
15.8 Natural Intelligence System Neuropace
15.9 Numenta
15.10 Qualcomm
15.11 Samasung Electronics Ltd
15.12 Vicarious

16 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/h13ns

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470 
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716 



SOURCE Research and Markets


These press releases may also interest you

at 03:00
Caledonia Mining Corporation Plc ("Caledonia" or the "Company")  announces its operating and financial results for the year ended December 31, 2023 (the "Year"). Further information on the financial and operating results for the Year and the quarter...

at 00:01
In advance of the upcoming NAB 2024 show, fan-streaming trailblazer Attention Seekers announced that it has selected Eluvio to provide the back-end technology platform for its next-generation Keystream service, a private press streaming service...

27 mar 2024
The "United States Self-Monitoring Blood Glucose Devices Market Growth, Share, Size, Trends, Analysis and Forecast (2024 - 2032)" report has been added to  ResearchAndMarkets.com's offering. The latest comprehensive research study has been added to...

27 mar 2024
The "Highly Potent API Market - A Global and Regional Analysis: Focus on Type, Type of Synthesis, Therapeutic Area, Type of Manufacturing, End User, and Country - Analysis and Forecast, 2023-2033" report has been added to  ResearchAndMarkets.com's...

27 mar 2024
Akebia Therapeutics®, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the U.S. Food and Drug Administration (FDA)...

27 mar 2024
The "Green Hydrogen Market - A Global and Regional Analysis: Focus on Application, Technology, Renewable Energy Source, and Region - Analysis and Forecast, 2023-2033" report has been added to  ResearchAndMarkets.com's offering. The global green...



News published on and distributed by: